BCL2 and breast carcinoma: Interestingly, basal levels of Bcl2, an anti-apoptotic molecule was undetectable in HCC-1806, while its levels dramatically declined in MDA-MB-468 and MDA-MB-157 AA TN breast cancer cells with NO treatment (Fig. 2a-b).